Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. American Antibiotics, Inc.
EIR
•American Antibiotics, Inc.•March 28, 2013

American Antibiotics, Inc. – FDA EIR, Mar 28, 2013

Record Details

An FDA inspection of American Antibiotics, Inc., a human beta-lactam antibiotic drug manufacturer located in Baltimore, MD, was conducted from March 4 to March 28, 2013. The inspection adhered to 21 CFR Parts 210 and 211, focusing on quality, production, laboratory controls, facilities and equipment, and packaging and labeling systems for their commercial Amoxicillin Capsules, USP. The inspection culminated in a five-item FDA Form 483, "Inspectional Observations." Key violations identified included the implementation of major changes to drug product impurity specifications without prior agency approval, insufficient training of production employees on operation-specific and quality assurance procedures, and a lack of scientifically sound specifications within laboratory controls to ensure drug product quality and purity following an API supplier change. Furthermore, deviations from written production and process control procedures were not recorded and justified, and labeling issuance control procedures were not consistently followed. Additional concerns discussed verbally with management involved the misclassification of deviations, inadequate validation for batch size alterations, reliance on only two months of accelerated stability data for a two-year expiry claim, the absence of formal complaint handling agreements with clients, and inadequate visual inspection during packaging operations. American Antibiotics management acknowledged the observations and committed to implementing corrective actions, including revising training protocols, updating complaint handling procedures, and enhancing packaging inspection processes. A written response to the 483 observations was promised within 15 business days.

Company
American Antibiotics, Inc.
Inspection date
March 28, 2013
Product type
RX (Prescription)
Office
Baltimore District Office
People
  • Rachel C. Harrington (Senior Advisor)
  • Mandeep K. Taneja (recipient)
  • Emily Leongini (issuing_officer)
  • Sushant K. Pradhan (recipient)
  • Chiang Syin (issuing_officer)
View Company Profile

ID · 2c5fdea3-2ce9-4989-9153-caf5c21a4308

Violation Codes7
21 CFR 211.160(b)21 CFR 211.100(b)21 CFR 21121 CFR 21021 CFR 314.70(b)21 CFR 211.25(a)21 CFR 211.125(f)

Full citation text and observation details available on the Dashboard.

Other documents for American Antibiotics, Inc.
  • EIR - 2015-12-18December 18, 2015
  • WARNING_LETTER - 2014-07-23July 23, 2014

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore American Antibiotics, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.